Concepedia

Radosław Polański

RP

19

Publications

1.8K

Citations

16

H-Index

2008

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

University of Liverpool

Cancer Research UK Manchester Institute

University of Manchester

Radosław Polański is an author at AstraZeneca (United Kingdom) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2008–2024

19

Publications

19

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

Cassandra L. Hodgkinson, Christopher J. Morrow, Yaoyong Li et al. · Nature Medicine · 2014 · 682 citations

, , +13

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer

Radosław Polański, Cassandra L. Hodgkinson, Alberto Fusi et al. · Clinical Cancer Research · 2013 · 345 citations · Full text

Vasculogenic mimicry in small cell lung cancer

Stuart C. Williamson, Robert Metcalf, Francesca Trapani et al. · Nature Communications · 2016 · 237 citations · Full text

Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist

James S. Scott, Amber Balazs, Bernard Barlaam et al. · Journal of Medicinal Chemistry · 2020 · 109 citations · Full text

The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance

Mandy Lawson, Natalie Cureton, Susana R�os et al. · Cancer Research · 2023 · 54 citations · Full text

Rows per page

1–5 of 19